MAA
GHDX

Managed Account Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Managed Account Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,815
Closed -$111K – 2671
2013
Q4 		$111K Sell
3,815
-100,400
-96% -$3.19M ﹤0.01% 2288
2013
Q3 		$3.19M Buy
104,215
+8,921
+9% +$298K ﹤0.01% 1466
2013
Q2 		$3.02M Buy
+95,294
New +$3.13M ﹤0.01% 1447

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Managed Account Advisors's GHDX Position: Q1 2014 in Review

Managed Account Advisors sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 3,815 shares — an estimated $111K sold.

Managed Account Advisors first reported a position in GHDX in Q2 2013 and held it in 3 quarters. The position peaked at $3.19M in Q3 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Managed Account Advisors reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Managed Account Advisors sold 3,815 Genomic Health, Inc. shares in Q1 2014, an estimated $111K.
  • Managed Account Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 3 quarters.
  • Managed Account Advisors's Genomic Health, Inc. position peaked at $3.19M in Q3 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Managed Account Advisors's 13F filing for Q1 2014, filed 15 May 2014.